Serum Collagen Markers and Heart Failure

J. Lijnen, P.; Maharani, T.; Finahari, N.; S. Prihadi, J.
June 2012
Cardiovascular & Haematological Disorders - Drug Targets;Jun2012, Vol. 12 Issue 1, p51
Academic Journal
Increased myocardial collagen accumulation is present in almost every cardiac disease and plays an important role in the reduced heart function. N-terminal and C-terminal propeptides of collagen type I and III, the two major collagen types in the heart, can be assayed in serum.These propeptides (PINP, PIIINP, PICP, ICTP) reflect collagen synthesis and degradation. The use of these serum collagen biomarkers as prognostic or diagnostic tools is an area of active investigation. In this review article these studies will be discussed as well as the limitations of these serum biomarkers as indicators of cardiac fibrosis.


Related Articles

  • Two biomarkers predicted higher risk for HF.  // Cardiology Today;Dec2010, Vol. 13 Issue 12, p1 

    The article reports on a biomarker panel that has been identified by researchers from Boston University which can predict the risk for heart failure (HF) in people without prevalent coronary heart disease.

  • Circulating microRNAs to identify human heart failure. Seto, Anita G.; van Rooij, Eva // European Journal of Heart Failure;Feb2012, Vol. 14 Issue 2, p118 

    No abstract available.

  • Biomarker predicts heart failure risk. Robinson, Stephen // GP: General Practitioner;11/19/2010, p8 

    The article presents information on a biomarker that can predict heart failure (HF). Reportedly, this biomarker can more accurately predict HF risks in elderly people than the existing models. The principle that it works on, is the levels of the protein cardiac tropin T (cTnT) that is linked to...

  • Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: A direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Hülsmann, Martin; Berger, Rudolf; Mörtl, Deddo; Gore, Odette; Meyer, Brigitte; Pacher, Richard // European Journal of Heart Failure;Jun2005, Vol. 7 Issue 4, p552 

    Abstract: Aims: N-ANP, N-BNP and BNP are proven to be excellent markers for diagnosis and the prediction of outcome in heart failure patients. Published studies on this subject differ in respect of their design and are therefore difficult to compare. The EuroHeart Failure Survey was undertaken...

  • Triiodothyronine and Brain Natriuretic Peptide. Kozdag, Guliz; Ertas, Gokhan; Kilic, Teoman; Acar, Eser; Sahin, Tayfun; Ural, Dilek // Texas Heart Institute Journal;2010, Vol. 37 Issue 5, p538 

    Although low levels of free triiodothyronine and high levels of brain natriuretic peptide have been shown as independent predictors of death in chronic heart failure patients, few studies have compared their prognostic values. The aim of this prospective study was to measure free...

  • Human Heart Failure: A Proteomics Perspective. Goel, Arvind; Rakwal, Randeep; Agrawal, Ganesh Kumar // Current Proteomics;Oct2007, Vol. 4 Issue 3, p174 

    Cardiac hypertrophy, interstitial fibrosis, and cardiac dysfunction ultimately lead to cardiac failure. Cardiac failure is one of the major causes of heart disease and death in our society. The molecular causes of heart diseases, like many other diseases, remain largely unknown. Recently,...

  • Outcomes from four studies using ST2 show strong clinical utility in managing heart failure patients hellip;. Pedersen, Amanda // Medical Device Daily;5/29/2012, Vol. 16 Issue 101, Special section p1 

    The article looks at the results of several studies about ST2, an emerging biomarker for heart disease, presented at the 2012 European Heart Failure Congress.

  • Carbohydrate Antigen-125 and N-Terminal Pro-Brain Natriuretic Peptide Levels. Ordu, Serkan; Ozhan, Hakan; Alemdar, Recai; Aydin, Mesut; Caglar, Onur; Yuksel, Hatice; Kandis, Hayati // Texas Heart Institute Journal;2012, Vol. 39 Issue 1, p30 

    Carbohydrate antigen-125 (CA-125) is emerging as a prognostic biomarker of risk in heart failure. In a prospective study, we compared the prognostic values of CA-125 and amino-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with stable heart failure. We enrolled 102 consecutive...

  • Tumor markers in heart failure. BACALBASA, Nicolae; GIREADA, Alexandra; BALESCU, Irina; BALALAU, Cristian; DIMITRIU, Mihai // Romanian Journal of Medical Practice;2016, Vol. 11 Issue 1, p18 

    It has been widely demonstrated that patients diagnosed with chronic heart failure present high levels of circulating neurohormones and inflammation markers which can secondarily induce an increase of the level of tumor markers such as CA 125, AFP, CEA, CA 15.3 or CA 19-9. This is a literature...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics